ACICLOVIR CLARIS 25 Mg/Ml Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

aciclovir claris 25 mg/ml concentrate for soln for inf

claris lifesciences (uk) limited - aciclovir - concentrate for soln for inf - 25 mg/ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors

Ondansetron-Claris Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron-claris

claris lifesciences australia pty ltd - ondansetron hydrochloride dihydrate -

Fluconazole 2 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

fluconazole 2 mg/ml solution for infusion

claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 milligram(s)/millilitre - triazole derivatives; fluconazole

FLUCONAZOLE Ireland - English - HPRA (Health Products Regulatory Authority)

fluconazole

claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 mg/ml - fluconazole

BUPIVACAINE 2.5 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

bupivacaine 2.5 mg/ml solution for injection

claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 2.5 mg/ml - amides

BUPIVACAINE 5.0 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

bupivacaine 5.0 mg/ml solution for injection

claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 5.0 mg/ml - amides

MESNA-CLARIS mesna 200 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

mesna-claris mesna 200 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - mesna, quantity: 100 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections; nitrogen; sodium hydroxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide and ifosfamide product information).

MESNA-CLARIS mesna 400 mg/4 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

mesna-claris mesna 400 mg/4 ml solution for injection ampoule

baxter healthcare pty ltd - mesna, quantity: 100 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; nitrogen; water for injections; disodium edetate - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide and ifosfamide product information).